Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Sarah Milgrom

Concepts (334)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hodgkin Disease
31
2023
120
8.690
 Why?
Positron Emission Tomography Computed Tomography
14
2023
63
3.060
 Why?
Radiotherapy, Intensity-Modulated
14
2019
124
2.500
 Why?
Fluorodeoxyglucose F18
7
2023
113
2.390
 Why?
Antineoplastic Combined Chemotherapy Protocols
28
2023
1355
2.230
 Why?
Radiotherapy
12
2020
176
1.970
 Why?
Lymphoma
8
2021
177
1.960
 Why?
Central Nervous System Neoplasms
9
2021
126
1.960
 Why?
Radiation Injuries
8
2021
128
1.890
 Why?
Radiopharmaceuticals
6
2023
157
1.800
 Why?
Neoplasm Staging
30
2021
1167
1.580
 Why?
Radiotherapy Planning, Computer-Assisted
11
2021
117
1.530
 Why?
Tumor Burden
5
2023
259
1.510
 Why?
Neoplasm Recurrence, Local
13
2023
858
1.450
 Why?
Lymphoma, Non-Hodgkin
5
2020
71
1.440
 Why?
Sarcoma
2
2023
137
1.410
 Why?
Lymphoma, Large B-Cell, Diffuse
7
2021
98
1.320
 Why?
Salvage Therapy
10
2020
127
1.270
 Why?
Endometrial Neoplasms
4
2014
141
1.250
 Why?
Mediastinal Neoplasms
5
2021
33
1.220
 Why?
Radiotherapy Dosage
15
2021
244
1.160
 Why?
Combined Modality Therapy
21
2021
1121
1.110
 Why?
Prognosis
22
2023
3327
1.080
 Why?
Hematopoietic Stem Cell Transplantation
6
2023
520
1.040
 Why?
Positron-Emission Tomography
7
2023
259
0.950
 Why?
Radiation
2
2020
24
0.880
 Why?
Radiation Exposure
1
2023
41
0.860
 Why?
Adenocarcinoma
3
2014
795
0.860
 Why?
Radiotherapy, Adjuvant
6
2019
182
0.860
 Why?
Humans
99
2023
114654
0.830
 Why?
Lymphoma, Follicular
5
2020
35
0.810
 Why?
Rhabdomyosarcoma
1
2023
54
0.800
 Why?
Sarcoma, Ewing
1
2023
64
0.790
 Why?
Smiling
1
2021
6
0.780
 Why?
Salivary Glands
2
2021
31
0.780
 Why?
Xerostomia
1
2021
19
0.750
 Why?
Tooth Abnormalities
1
2021
12
0.750
 Why?
Retrospective Studies
36
2023
12544
0.750
 Why?
Aged
41
2020
19068
0.730
 Why?
Brachytherapy
1
2021
103
0.730
 Why?
Chemoradiotherapy
9
2021
188
0.710
 Why?
Middle Aged
48
2020
26732
0.700
 Why?
Proton Therapy
1
2020
10
0.700
 Why?
Neoplasms
3
2023
2097
0.700
 Why?
Aged, 80 and over
21
2020
6345
0.700
 Why?
Face
1
2021
164
0.690
 Why?
Doxorubicin
12
2020
285
0.680
 Why?
Intraocular Lymphoma
2
2016
2
0.660
 Why?
Adult
50
2023
30542
0.660
 Why?
Young Adult
29
2023
10465
0.650
 Why?
Rectal Neoplasms
3
2016
121
0.640
 Why?
Bleomycin
8
2020
228
0.640
 Why?
Lymphoma, B-Cell, Marginal Zone
4
2019
11
0.630
 Why?
Cerebellar Neoplasms
1
2020
130
0.620
 Why?
Medulloblastoma
1
2020
172
0.610
 Why?
Vinblastine
8
2020
63
0.610
 Why?
Dacarbazine
8
2020
99
0.600
 Why?
Recurrence
9
2020
935
0.580
 Why?
Cancer Survivors
1
2021
205
0.570
 Why?
Leukemia, Myeloid, Acute
2
2023
534
0.560
 Why?
Head and Neck Neoplasms
1
2021
427
0.550
 Why?
Meningeal Neoplasms
1
2018
87
0.550
 Why?
Leukemia, Biphenotypic, Acute
1
2016
3
0.540
 Why?
Patient Satisfaction
1
2020
578
0.540
 Why?
Brain Neoplasms
3
2023
979
0.540
 Why?
Breast Neoplasms
5
2019
1862
0.540
 Why?
Female
54
2020
59488
0.520
 Why?
Treatment Outcome
24
2020
9087
0.510
 Why?
Eye Diseases
1
2016
76
0.490
 Why?
Survival Rate
12
2021
1644
0.490
 Why?
Child
14
2023
18407
0.480
 Why?
Follow-Up Studies
15
2020
4411
0.470
 Why?
Glycolysis
3
2023
227
0.460
 Why?
Graft vs Host Disease
1
2016
212
0.460
 Why?
Male
48
2021
55579
0.460
 Why?
Disease-Free Survival
12
2020
620
0.460
 Why?
Stomach Neoplasms
3
2019
65
0.450
 Why?
Endometrium
1
2013
60
0.430
 Why?
Peritoneal Cavity
1
2013
23
0.430
 Why?
Digestive System Surgical Procedures
1
2014
91
0.430
 Why?
Lymphoma, B-Cell
3
2021
86
0.430
 Why?
Neoadjuvant Therapy
2
2016
304
0.420
 Why?
Palate, Hard
1
2012
4
0.420
 Why?
Infertility, Female
1
2013
94
0.420
 Why?
Disease Progression
6
2019
2380
0.410
 Why?
Chemoradiotherapy, Adjuvant
3
2019
40
0.410
 Why?
Image Enhancement
1
2013
158
0.410
 Why?
Mastectomy, Simple
1
2012
1
0.410
 Why?
Adolescent
21
2023
17837
0.390
 Why?
Carcinoma, Lobular
1
2012
44
0.390
 Why?
Sentinel Lymph Node Biopsy
1
2012
99
0.380
 Why?
Carcinoma, Ductal, Breast
1
2012
76
0.380
 Why?
Adrenal Gland Neoplasms
1
2012
81
0.370
 Why?
Organs at Risk
3
2020
30
0.360
 Why?
Tomography, X-Ray Computed
7
2023
2285
0.360
 Why?
Disease Management
6
2019
560
0.350
 Why?
Biopsy
6
2020
1036
0.340
 Why?
Radiotherapy, Image-Guided
3
2019
30
0.340
 Why?
Cellulitis
1
2009
45
0.330
 Why?
Carcinoma, Squamous Cell
1
2014
577
0.320
 Why?
Kaplan-Meier Estimate
7
2020
811
0.320
 Why?
Lymphocytes
3
2020
330
0.310
 Why?
Multiple Myeloma
2
2020
93
0.300
 Why?
Lymphoma, Mantle-Cell
2
2019
18
0.300
 Why?
Survival Analysis
6
2020
1211
0.270
 Why?
Cardiotoxicity
2
2023
27
0.270
 Why?
Pregnancy Complications, Neoplastic
2
2017
50
0.270
 Why?
Patient Selection
2
2022
641
0.270
 Why?
Testicular Neoplasms
2
2018
96
0.260
 Why?
Radiation Pneumonitis
2
2016
24
0.260
 Why?
Magnetic Resonance Imaging
4
2019
3044
0.260
 Why?
Risk Assessment
6
2023
2968
0.250
 Why?
Heart
3
2018
612
0.250
 Why?
Lymph Node Excision
2
2019
139
0.250
 Why?
Antimetabolites, Antineoplastic
2
2017
81
0.240
 Why?
Leukemia
2
2017
209
0.240
 Why?
Risk Factors
5
2021
8631
0.240
 Why?
Central Nervous System
3
2021
235
0.230
 Why?
Mediastinum
3
2019
22
0.230
 Why?
Consensus
2
2023
537
0.230
 Why?
Lymphatic Metastasis
3
2014
275
0.220
 Why?
Postoperative Complications
1
2014
2128
0.220
 Why?
Lymphadenopathy
1
2023
8
0.220
 Why?
Neoplasm Grading
4
2019
242
0.210
 Why?
Remission Induction
3
2018
233
0.210
 Why?
Protons
2
2020
73
0.200
 Why?
Survivors
2
2023
411
0.200
 Why?
Transplantation, Autologous
3
2018
176
0.200
 Why?
Chemotherapy, Adjuvant
2
2013
332
0.200
 Why?
Brain Stem Neoplasms
1
2023
86
0.200
 Why?
Radiometry
2
2019
42
0.200
 Why?
Gastric Mucosa
2
2019
46
0.200
 Why?
Multimodal Imaging
3
2017
88
0.200
 Why?
Mitogen-Activated Protein Kinase 7
1
2021
15
0.190
 Why?
Poly(ADP-ribose) Polymerases
1
2021
88
0.190
 Why?
Radium
1
2020
3
0.180
 Why?
Breath Holding
2
2017
6
0.180
 Why?
Long Term Adverse Effects
1
2020
10
0.180
 Why?
Cranial Irradiation
2
2023
66
0.180
 Why?
Whole-Body Irradiation
1
2020
73
0.170
 Why?
Stem Cell Transplantation
2
2018
149
0.170
 Why?
Skin Neoplasms
2
2018
756
0.170
 Why?
Cardiology
1
2022
259
0.170
 Why?
Child, Preschool
4
2023
9111
0.170
 Why?
Postoperative Care
2
2019
222
0.170
 Why?
Glioma
1
2023
294
0.170
 Why?
Radiation Dosage
1
2020
133
0.160
 Why?
Plasmacytoma
1
2019
9
0.160
 Why?
CD4-CD8 Ratio
1
2018
19
0.160
 Why?
Mycosis Fungoides
1
2018
60
0.160
 Why?
Methotrexate
2
2017
226
0.160
 Why?
Peritoneal Neoplasms
1
2019
54
0.160
 Why?
Electrons
1
2018
71
0.150
 Why?
Area Under Curve
1
2019
274
0.150
 Why?
Breast Neoplasms, Male
1
2018
28
0.150
 Why?
Radiotherapy Setup Errors
1
2017
3
0.150
 Why?
Autografts
1
2018
40
0.150
 Why?
Platelet Count
1
2017
81
0.150
 Why?
Hypothyroidism
1
2018
64
0.150
 Why?
Craniospinal Irradiation
1
2017
4
0.140
 Why?
Dendritic Cell Sarcoma, Follicular
1
2017
2
0.140
 Why?
Vincristine
4
2019
98
0.140
 Why?
Eye Neoplasms
1
2017
16
0.140
 Why?
Leukocyte Count
1
2017
293
0.140
 Why?
Uncertainty
1
2017
95
0.140
 Why?
Predictive Value of Tests
3
2022
1796
0.140
 Why?
Spinal Cord Diseases
1
2017
38
0.140
 Why?
Neoplasm, Residual
1
2017
104
0.140
 Why?
Osteogenesis Imperfecta
2
2007
13
0.140
 Why?
Pentostatin
1
2016
1
0.140
 Why?
Axilla
2
2017
39
0.140
 Why?
Photopheresis
1
2016
9
0.140
 Why?
Anxiety
1
2023
840
0.140
 Why?
Drug Resistance, Neoplasm
2
2019
636
0.130
 Why?
Collagen Type I
2
2007
108
0.130
 Why?
Methylprednisolone
1
2016
81
0.130
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2016
98
0.130
 Why?
Plasmablastic Lymphoma
1
2015
6
0.130
 Why?
Confidence Intervals
1
2016
305
0.130
 Why?
Antibiotics, Antineoplastic
1
2016
109
0.130
 Why?
Congenital Abnormalities
1
2016
73
0.130
 Why?
Abortion, Spontaneous
1
2016
90
0.130
 Why?
Fatal Outcome
1
2016
284
0.130
 Why?
Hysterectomy
2
2013
106
0.130
 Why?
Coronary Artery Disease
1
2021
607
0.130
 Why?
Biomarkers
4
2021
3408
0.130
 Why?
Tacrolimus
1
2016
134
0.130
 Why?
Proportional Hazards Models
4
2020
1075
0.120
 Why?
Transplantation, Homologous
1
2016
377
0.120
 Why?
Blood Platelets
1
2017
351
0.120
 Why?
Age Factors
1
2021
2894
0.110
 Why?
Antineoplastic Agents
4
2019
1879
0.110
 Why?
Risk
1
2016
812
0.110
 Why?
Caregivers
1
2020
717
0.110
 Why?
Kidney Neoplasms
1
2018
327
0.110
 Why?
Etoposide
3
2018
148
0.110
 Why?
Receptors, Progesterone
2
2014
319
0.110
 Why?
Receptor, ErbB-2
2
2014
300
0.110
 Why?
Cyclophosphamide
3
2019
217
0.110
 Why?
Lung
2
2016
3559
0.110
 Why?
Rituximab
3
2019
150
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2021
961
0.110
 Why?
Receptors, Estrogen
2
2014
372
0.110
 Why?
Spinal Cord
1
2015
347
0.110
 Why?
Carboplatin
1
2013
135
0.110
 Why?
Anti-Inflammatory Agents
1
2016
447
0.100
 Why?
Fluorouracil
1
2013
152
0.100
 Why?
Pelvis
1
2013
90
0.100
 Why?
Radiotherapy, Conformal
1
2012
68
0.100
 Why?
Neutrophils
1
2017
1176
0.100
 Why?
Immunosuppressive Agents
1
2016
646
0.100
 Why?
Paclitaxel
1
2013
190
0.100
 Why?
Health Knowledge, Attitudes, Practice
1
2020
1183
0.100
 Why?
Brain
2
2020
2371
0.100
 Why?
Cisplatin
1
2013
262
0.100
 Why?
Immunohistochemistry
1
2016
1629
0.100
 Why?
Immunoenzyme Techniques
1
2012
192
0.100
 Why?
Immunotherapy
1
2015
474
0.100
 Why?
Triple Negative Breast Neoplasms
1
2014
157
0.100
 Why?
Models, Biological
1
2018
1620
0.090
 Why?
Contrast Media
1
2013
345
0.090
 Why?
Liver Neoplasms
1
2014
506
0.090
 Why?
Cohort Studies
5
2018
4895
0.090
 Why?
Prospective Studies
3
2021
6217
0.090
 Why?
Polymorphism, Single Nucleotide
1
2016
1879
0.080
 Why?
Patient Compliance
1
2013
525
0.080
 Why?
Lung Neoplasms
1
2021
2177
0.080
 Why?
Dose-Response Relationship, Radiation
2
2020
127
0.080
 Why?
United States
2
2021
12179
0.080
 Why?
Colorectal Neoplasms
1
2014
615
0.070
 Why?
Antibodies, Monoclonal, Murine-Derived
2
2019
82
0.070
 Why?
Biomarkers, Tumor
1
2014
1040
0.070
 Why?
Prednisone
2
2019
229
0.070
 Why?
Practice Guidelines as Topic
1
2014
1394
0.070
 Why?
Time Factors
4
2018
6115
0.070
 Why?
Cytarabine
2
2018
51
0.070
 Why?
Integrins
1
2007
79
0.070
 Why?
Proteoglycans
1
2007
107
0.070
 Why?
Treatment Failure
2
2018
331
0.070
 Why?
Glycine
1
2006
152
0.060
 Why?
Clinical Decision-Making
2
2019
268
0.060
 Why?
Amino Acid Substitution
1
2006
262
0.060
 Why?
Neoplasm Invasiveness
2
2017
442
0.060
 Why?
X-ray Repair Cross Complementing Protein 1
1
2023
14
0.060
 Why?
Intelligence Tests
1
2023
58
0.060
 Why?
X-Rays
1
2023
30
0.050
 Why?
Phenotype
3
2021
2796
0.050
 Why?
Regression Analysis
2
2016
944
0.050
 Why?
Proto-Oncogene Proteins c-sis
1
2023
35
0.050
 Why?
Inducible T-Cell Co-Stimulator Protein
1
2022
9
0.050
 Why?
Analysis of Variance
2
2016
1226
0.050
 Why?
Cytidine Deaminase
1
2023
58
0.050
 Why?
Brain Stem
1
2023
101
0.050
 Why?
Ribose
1
2021
18
0.050
 Why?
Adenosine Diphosphate
1
2021
81
0.050
 Why?
Poly (ADP-Ribose) Polymerase-1
1
2021
40
0.050
 Why?
Troponin T
1
2021
49
0.050
 Why?
Feedback
1
2021
144
0.050
 Why?
Prevalence
2
2016
2250
0.040
 Why?
Automation
1
2020
73
0.040
 Why?
Neoplasms, Radiation-Induced
1
2020
67
0.040
 Why?
Incidence
2
2016
2312
0.040
 Why?
Neuropsychological Tests
1
2023
927
0.040
 Why?
Risk Management
1
2020
89
0.040
 Why?
Workflow
1
2020
133
0.040
 Why?
Neoplasms, Second Primary
1
2020
92
0.040
 Why?
Mesentery
1
2019
53
0.040
 Why?
Safety
1
2020
297
0.040
 Why?
Busulfan
1
2018
14
0.040
 Why?
Melphalan
1
2018
29
0.040
 Why?
Respiration
1
2019
180
0.040
 Why?
Carmustine
1
2018
47
0.040
 Why?
Time-to-Treatment
1
2019
147
0.040
 Why?
Cone-Beam Computed Tomography
1
2017
25
0.040
 Why?
Inhalation
1
2017
26
0.040
 Why?
Breast
1
2018
139
0.040
 Why?
Subacute Combined Degeneration
1
2017
1
0.040
 Why?
Phosphorylation
1
2021
1569
0.040
 Why?
Deoxycytidine
1
2018
138
0.040
 Why?
Photons
1
2017
57
0.030
 Why?
Organ Sparing Treatments
1
2017
31
0.030
 Why?
Injections, Spinal
1
2017
101
0.030
 Why?
Orbit
1
2017
59
0.030
 Why?
Lymph Nodes
1
2019
419
0.030
 Why?
New York
1
2016
106
0.030
 Why?
Mutation
1
2007
3345
0.030
 Why?
Animals
2
2021
31698
0.030
 Why?
Homocysteine
1
2017
136
0.030
 Why?
Mitochondria
1
2021
747
0.030
 Why?
Procarbazine
1
2015
8
0.030
 Why?
Observer Variation
1
2016
295
0.030
 Why?
Transforming Growth Factor beta1
1
2016
153
0.030
 Why?
Folic Acid
1
2017
161
0.030
 Why?
Genetic Markers
1
2016
320
0.030
 Why?
Texas
1
2016
188
0.030
 Why?
Pregnancy
2
2017
5517
0.030
 Why?
Molecular Targeted Therapy
1
2018
347
0.030
 Why?
Abortion, Induced
1
2016
71
0.030
 Why?
Pregnancy Outcome
1
2017
337
0.030
 Why?
Gastrointestinal Diseases
1
2016
182
0.030
 Why?
Diagnostic Imaging
1
2017
275
0.030
 Why?
Secondary Prevention
1
2016
222
0.030
 Why?
Drug Administration Schedule
1
2016
718
0.030
 Why?
Acute Disease
1
2016
910
0.030
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
256
0.030
 Why?
Postpartum Period
1
2016
278
0.030
 Why?
CD8-Positive T-Lymphocytes
1
2018
687
0.030
 Why?
Mastectomy
1
2014
99
0.030
 Why?
Ultrasonography
1
2016
633
0.030
 Why?
CD4-Positive T-Lymphocytes
1
2018
959
0.030
 Why?
Diagnosis, Differential
1
2017
1342
0.030
 Why?
Multivariate Analysis
1
2016
1430
0.030
 Why?
Medical Oncology
1
2014
229
0.030
 Why?
Ovariectomy
1
2012
116
0.030
 Why?
Comorbidity
1
2016
1448
0.020
 Why?
Severity of Illness Index
1
2019
2537
0.020
 Why?
Quality of Life
1
2021
2353
0.020
 Why?
Electronic Health Records
1
2017
800
0.020
 Why?
Kidney
1
2017
1188
0.020
 Why?
Diet
1
2017
1080
0.020
 Why?
Anti-Bacterial Agents
1
2019
1481
0.020
 Why?
Reproducibility of Results
1
2016
2762
0.020
 Why?
Genetic Predisposition to Disease
1
2016
2085
0.020
 Why?
Infant
1
2020
7959
0.020
 Why?
Case-Control Studies
1
2014
3003
0.020
 Why?
Electrophoresis
1
2006
26
0.020
 Why?
DNA Mutational Analysis
1
2007
372
0.020
 Why?
Databases, Genetic
1
2007
206
0.020
 Why?
Mice
1
2021
14863
0.020
 Why?
Collagen
1
2007
415
0.010
 Why?
Protein Structure, Tertiary
1
2007
796
0.010
 Why?
Binding Sites
1
2007
1168
0.010
 Why?
Protein Binding
1
2007
1889
0.010
 Why?
Cells, Cultured
1
2006
3885
0.010
 Why?
Milgrom's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (334) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)